High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix composition
Open Access
- 12 November 2007
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 209
Abstract
Smad4 is a tumour suppressor frequently inactivated in pancreatic and colorectal cancers. We have recently reported loss of Smad4 in every fourth carcinoma of the uterine cervix. Smad4 transmits signals from the TGF-β superfamily of cytokines and functions as a versatile transcriptional co-modulator. The prevailing view suggests that the tumour suppressor function of Smad4 primarily resides in its capability to mediate TGF-β growth inhibitory responses. However, accumulating evidence indicates, that the acquisition of TGF-β resistance and loss of Smad4 may be independent events in the carcinogenic process. Through inducible reexpression of Smad4 in cervical cancer cells we wished to shed more light on this issue and to identify target genes implicated in Smad4 dependent tumor suppression.Keywords
This publication has 44 references indexed in Scilit:
- The logic of TGFβ signalingFEBS Letters, 2006
- βig-h3 Induces Keratinocyte Differentiation via Modulation of Involucrin and Transglutaminase Expression through the Integrin α3β1 and the Phosphatidylinositol 3-Kinase/Akt Signaling PathwayJournal of Biological Chemistry, 2005
- Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancerInternational Journal of Cancer, 2004
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Loss of Smad4 correlates with loss of the invasion suppressor E‐cadherin in advanced colorectal carcinomasThe Journal of Pathology, 2004
- TGF-β antagonists: Why suppress a tumor suppressor?Journal of Clinical Investigation, 2002
- Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer CellsJournal of Biological Chemistry, 1999
- DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expressionOncogene, 1999
- Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasisOncogene, 1999
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996